title: Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.
authors.affiliation: Cancer Prevention, Detection and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Suite 602, Box 2949, 2424 Erwin Road, Durham, NC 27710, USA. patricia.moorman@duke.edu
authors.forename: Patricia G
authors.initials: PG
authors.lastname: Moorman
authors.forename: John
authors.initials: J
authors.lastname: Sesay
authors.forename: Veronica
authors.initials: V
authors.lastname: Nwosu
authors.forename: Janet Grubber
authors.initials: JG
authors.lastname: Kane
authors.forename: Allan René
authors.initials: AR
authors.lastname: de Cotret
authors.forename: Kendra
authors.initials: K
authors.lastname: Worley
authors.forename: Robert
authors.initials: R
authors.lastname: Millikan
mesh_terms: D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D044383:Black People; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics* / Q000517:prevention & control; D051546:Cyclooxygenase 2 / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D009657:North Carolina / Q000453:epidemiology; D011110:Polymorphism, Genetic; D014481:United States / Q000453:epidemiology; D001741:Black or African American
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D051546:Cyclooxygenase 2